What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. Read more exciting novels for free
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Are there any drugs for treating cancer and tumors abroad?
Foreign anti-cancer drugs included the following categories: 1. ** Target therapy drugs **: such as trastuzan, aflatini, gefitini, bugatini, bevacizumi, adamantib (Humira), lenalidomide (Revlimid), etc. 2. * * 3. ** Immune therapy drugs **: Nivulumab, palivibizab, etc. 4. ** Chemotherapy drugs **: taxol, gemcitobin, oxaliplatinum, capecitobin, etc. 5. ** New oral hemostatic drug (supplementary drug related to cancer treatment)**: Apixaban (Alerto). 6. ** Small Molecules Inhibition of proliferating proliferating cell proliferations **: AOh1996, developed by researchers in the City of Hope on August 1, 2023, has growth inhibition effects on more than 70 solid tumor cancer cell lines. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What targeted drugs can be taken for oral cancer?
The targeted drugs for oral squamous-cell cancer included pabolizumab injection, trastubizab for injection, erlotinib, gefitinib, cetuxed, nivaliumab, etc. Pabolizub injection can be used to treat advanced non-small cell lung cancer, advanced gastric cancer, oral Squamoma, etc.; Trastuzu for injection can be used to treat metastasized breast cancer, metastasized gastric cancer, oral Squamoma, etc.; Erlotinib is suitable for patients with advanced non-small cell lung cancer who have a mutation in Exon 19 or L858 of the Epidermal growth factor receptor Tyrosin Kinase gene. It can block the egf-signaling pathway to inhibit the growth of tumor cells; Gefitini can be used for the treatment of patients with locally advanced or metastasized non-small cell lung cancer who have failed at least one previous chemotherapy program. It can selectively inhibit the activity of EGFR protein protein. Cetuxed is suitable for the auxiliary treatment of RAS gene wild-type Colon Cancer, Rectal Cancer, and Stomach Cancer. It can be used in combination with radiation to improve the efficacy. Nivaliumab is suitable for the treatment of patients with advanced liver cancer who have failed previous systematic treatment. It activates T cells, allowing them to recognize and attack tumor cells that express the PD - 1 receptor. When using these drugs, you must follow the doctor's advice and pay attention to their respective conditions and precautions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of targeted drugs for head and neck cancer?
As for head and neck tumors, because most head and neck tumors occur in the mucus membrane, more than 90% of them are positive for the receptor for the growth factor of the human skin. Target drugs such as cetuxed mainly act on the growth factor of the human skin. Cetuxed combined with chemotherapy can achieve better efficacy in the treatment of head and neck tumors and reduce tumor relapse and migration. In addition, Bevacobin, Duostat, etc. can inhibit tumor neoplasia and thus tumor growth. However, there was no specific mention of targeted drugs for head and neck adenomas. There was only information on targeted drugs for head and neck tumors. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What medicine is effective in treating liver cancer with targeted therapy?
The following drugs are effective in targeted therapy for liver cancer: 1. Sorafenib: This is a multi-target inhibition drug that suppresses the growth of liver cancer cells and increases their cell death. clinical trials have shown that it can significantly prolong the survival of patients. 2. Rituxan: As a monoclonal-type antibody1, it can bind to the Epidermal Growth Factor1 receptor on the surface of tumor cells and suppress the growth and invasion of liver cancer cells. 3. Oracle Bone Inscription: A kind of human-derived monoclonal-type antibody-specific for liver cancer. By binding to the GCP3 protein on the surface of liver cancer cells, it suppresses the growth and invasion of liver cancer cells. 4. <strong></strong><strong></strong><strong></strong> 5. Regorafenib and lenvatini: targeted drugs for anti-tumor neoplasia. 6. Apatini: It can also be used for targeted therapy of liver cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the types of immune drugs for treating liver cancer?
There are mainly the following types of immune drugs for treating liver cancer: 1. immune regulator, such as Interferon and thymosin. 2. Immune checkpoint blockade agents, including drugs related to PD - 1, such as arbetacini (atezolizu), a humanized IgG1 class 1 monoclonal-type antibody-enhancing immune response by suppressing the binding of PD-L1 to its receptor, PD - 1; pembrolizumab (Pembrolifabricate), a human-derived IgG4 class 4 monoclone, which suppresses the binding of PD-L1 and PD-L1 to enhance the body's immune attack on tumor cells; Nibellifabricate (Nivioluba), a human-derived IgG4 class monoclonal-type anti-body that suppresses the combination of PD-L1 and PD-L1 to enhance the body's immune system's attack on liver cancer cells. There were also China's first approved liver cancer PD-L1-type anti-body drugs, such as Erika. Common drugs were also Odivo and Keruida. 3. Tumour vaccine, such as the Dendritic Cell vaccine. 4. Cell immune therapy drugs, such as Cycline-induced Killer Cell (CIK). 5. There was also the T-cell proliferator-1 (CTLA - 4), which could stimulate the immune system and promote the reproduction and differentiation of T cells, thereby enhancing the immune response to liver cancer. Ipilimin, a human-derived IgG1 class of monoclonal-type, could enhance the immune system's attack on liver cancer by activating T cells. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How long will it take for targeted drugs to be effective for lung cancer?
Patients with lung cancer usually took targeted drugs for ten days, no more than forty days, and the effect would take effect in two to three days. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the side effects of targeted drugs for head and neck cancer?
Different types of targeted drugs had different side effects. If it was a targeted drug with a positive expression of HER - 2, the main side effect might be diarrhea. If it was combined with other chemotherapy drugs, it might also cause white blood cell and Platelet decrease, fatigue, etc.; Monocentric antibody-targeted drugs may cause side effects such as high blood pressure, proteuria, liver and kidney function abnormalities; Tyrosinase kinases that target gene mutations may cause side effects such as rash, itching, mucus membrane inflammation, oral ulcers, diarrhea, etc. In addition, targeted drugs generally may also have digestive toxicity, such as loss of appetite, nausea, abdominal distension, abdominal pain, vomiting, diarrhea, etc.; general allergic reactions such as skin itching, redness, hair loss, blackening of nails, cracks, peeling, chapped skin, and general rashes; liver toxicity such as increased body indicators such as direct Bilirubin, indirect Bilirubin, Altaic Pyrutanase, etc.; cardiovascular reactions such as increased blood pressure, proteinuria, etc., as well as damage to the skin, such as decreased skin resistance. There were pustules, itchy skin, chapped skin, abnormal nails, and hair loss. However, there was no specific description of the side effects of targeted drugs for head and neck cancer. The side effects might cover these aspects. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>